YOUR GO-TO INTELLIGENCE RESOURCE FOR THE SCHOLARLY PUBLISHING INDUSTRY

Elsevier Health, a global leader in medical information and data analytics, has launched ClinicalKey AI, the first and most advanced clinical decision support tool to be introduced in the US that combines the latest and most trusted medical content with generative artificial intelligence (AI) to help clinicians at the point of care. ClinicalKey AI has been launched in partnership with OpenEvidence, a company specializing in AI for medicine.

Access to reliable, evidence-based medical information is critical, especially given the overwhelming volume of complex cases that clinicians are required to manage daily. In addition, staffing challenges are placing increasing demands on clinicians’ time, further amplifying the need for quick and secure access to accurate, trusted information at the point of care. ClinicalKey AI addresses this challenge by leveraging a sophisticated and personalized conversational search interface to help clinicians find accurate, succinct clinical information drawing from one of the world’s largest and most trusted body of medical information available to date. The solution has been designed to provide high-quality curated content and constantly refreshed evidence-based research to help clinicians in offering optimal patient experiences whether in a small clinic or a large hospital.

ClinicalKey AI’s search interface includes the following features: Optimized for natural language queries; Accurate information from multiple evidence-based content sources, including Elsevier’s large corpus of peer-reviewed content and other validated sources; Generates a summarized response based on evidence-based content sources and cited with references; Consideration to patient context, such as comorbidities and current medications, when prompted; Personalized responses based on the clinician’s profile; Ability to ask follow-up questions and to access previous queries and responses; All content is licensed so clinicians and institutions can feel confident in the information they are using.

Elsevier Health and OpenEvidence collaborated with Cone Health and the University of New Mexico on the development of ClinicalKey AI, which was also used by more than 30,000 physicians across the US.

ClinicalKey AI is built and maintained to deliver the accuracy and relevance of insights that healthcare institutions and physicians expect from Elsevier Health. ClinicalKey AI is HIPAA compliant and has been developed in line with Elsevier's Responsible AI Principles and Privacy Principles. ClinicalKey AI builds on Elsevier Health’s flagship offering ClinicalKey, which is used by thousands of hospital systems and medical schools across the globe to address point of care and deep reference needs.

For more than two decades, Elsevier has been using AI and machine learning technologies in combination with world-class peer-reviewed content and extensive data sets to create products that help the research, life sciences, and healthcare communities be more effective every day. By incorporating generative AI in its offerings, Elsevier aims to make it easier and more intuitive for customers to find the information they can trust to accelerate scientific discovery, empower collaboration, and transform patient care.

With unprecedented interest in ClinicalKey AI after an early access release in November 2023, ClinicalKey AI is now fully available across the US with launches in other geographies to be announced at a later date.